Page 1 of 1

Curiosity

Posted: Thu Jun 11, 2026 9:35 pm
by Alehax
What do you think about the new drug Rifasutenizol ?

Re: Curiosity

Posted: Fri Jun 12, 2026 4:42 pm
by Helico_expert
Rifasutenizol is an interesting compound. It is a fixed-dose combination of rifabutin and metronidazole, designed to hit the bacterium through two distinct targets simultaneously: rifabutin inhibits the β-subunit of bacterial DNA-dependent RNA polymerase (encoded by rpoB), while metronidazole is reduced under low-oxygen conditions and releases toxic metabolites that damage bacterial DNA.

Rifabutin is primarily reserved for mycobacterial infections such as tuberculosis, so widespread use could theoretically drive cross-resistance in M. tuberculosis. However, rifabutin does not share resistance with clarithromycin, metronidazole or levofloxacin in H. pylori.

Clinical data from China look promising. In a phase 2b trial, a triple regimen of 400 mg rifasutenizol plus rabeprazole and amoxicillin twice daily for 14 days achieved a 95% eradication rate (95% CI 74–100), and a 7-day course of 600 mg three times daily reached 100% (69–100). The high success rates may partly reflect the low baseline use of rifabutin in China, meaning pre-existing resistance is rare. That said, metronidazole resistance in China is already very high, pooled data show roughly 78% (73–84%) in 2016–2020, and over 90% in some regions, so the metronidazole component of rifasutenizol may contribute less than the rifabutin component in many patients.

Finally, H. pylori is not as intrinsically sensitive to rifabutin as it is to amoxicillin, tetracycline or furazolidone. Resistance to rifabutin can emerge readily through rpoB mutations, much like resistance to clarithromycin, metronidazole or fluoroquinolones. Therefore, while rifasutenizol appears effective, it should be used judiciously, most likely as a rescue or second-line option rather than first-line therapy.

Re: Curiosity

Posted: Mon Aug 17, 2026 3:07 pm
by daisymaria
I’d be interested in learning more about Rifasutenizol, including what condition it is designed to treat, how effective it has been in clinical studies, and what potential side effects or risks may be involved. New medicines can be promising, but I think reliable medical evidence and professional guidance are essential before drawing conclusions. EaglerCraft

Re: Curiosity

Posted: Tue Sep 15, 2026 12:19 pm
by hostilemusician
A topic that shares fresh, new insights, enticing you to explore and delve deeper. One of Sprunki Game's most notable features is its capacity to transform each character into an important part of the music-making process. The drag-and-drop gameplay enables players to quickly create a sound ensemble with a few easy movements. Because each character produces a distinct sound, the decision to include them in the mix has a direct impact on the final rhythm.

Re: Curiosity

Posted: Tue Sep 15, 2026 3:31 pm
by riya01
Booked for an evening near Aerocity and everything went as planned. She was polite, stylish and kept the conversation natural. Trying Russian Aerocity Escort for the first time worked out really well.